Top > Project Overview > Project　Overview

Y's Therapeutics focuses on developing monoclonal antibody therapies and other molecular-targeted biological drugs for the treatment of inflammation-mediated diseases, cancer, and other unmet medical needs. We also have small molecule compounds in our R&D pipeline to diversify our portfolio.

Our R&D pipeline has six on-going projects. YSPSL is a recombinant molecule project, which prevents tissue damage around the blood vessel from inappropriate inflammation. YSCMA is a humanized monoclonal antibody project for solid tumors and hematological malignancies. YSIL6 is a research project targeting rheumatoid arthritis.